BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 36102692)

  • 1. Multidomain peptide hydrogel adjuvants elicit strong bias towards humoral immunity.
    Pogostin BH; Yu MH; Azares AR; Euliano EM; Lai CSE; Saenz G; Wu SX; Farsheed AC; Melhorn SM; Graf TP; Woodside DG; Hartgerink JD; McHugh KJ
    Biomater Sci; 2022 Oct; 10(21):6217-6229. PubMed ID: 36102692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Powerful Complex Immunoadjuvant Based on Synergistic Effect of Combined TLR4 and NOD2 Activation Significantly Enhances Magnitude of Humoral and Cellular Adaptive Immune Responses.
    Tukhvatulin AI; Dzharullaeva AS; Tukhvatulina NM; Shcheblyakov DV; Shmarov MM; Dolzhikova IV; Stanhope-Baker P; Naroditsky BS; Gudkov AV; Logunov DY; Gintsburg AL
    PLoS One; 2016; 11(5):e0155650. PubMed ID: 27187797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vault nanocapsules as adjuvants favor cell-mediated over antibody-mediated immune responses following immunization of mice.
    Kar UK; Jiang J; Champion CI; Salehi S; Srivastava M; Sharma S; Rabizadeh S; Niazi K; Kickhoefer V; Rome LH; Kelly KA
    PLoS One; 2012; 7(7):e38553. PubMed ID: 22808011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Supramolecular peptide hydrogel adjuvanted subunit vaccine elicits protective antibody responses against West Nile virus.
    Friedrich BM; Beasley DWC; Rudra JS
    Vaccine; 2016 Nov; 34(46):5479-5482. PubMed ID: 27670075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A TLR7 Agonist Conjugated to a Nanofibrous Peptide Hydrogel as a Potent Vaccine Adjuvant.
    Euliano EM; Pogostin BH; Agrawal A; Yu MH; Baryakova TH; Graf TP; Hartgerink JD; McHugh KJ
    bioRxiv; 2024 Mar; ():. PubMed ID: 38496534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation of Modified Konjac Glucomannan Nanoparticles and their Application as Vaccine Adjuvants to Promote Ovalbumin-Induced Immune Response in Mice.
    Chen N; Zhu P; Du T; Han K; Wang D; Ye J; Xiao S; Ye X; Wang Y
    Pharm Res; 2018 Mar; 35(5):105. PubMed ID: 29560565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amino acid sequence determines the adjuvant potency of a D-tetra-peptide hydrogel.
    Zhang Y; Hu Z; Li X; Ding Y; Zhang Z; Zhang X; Zheng W; Yang Z
    Biomater Sci; 2022 Jun; 10(12):3092-3098. PubMed ID: 35522938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simple nanoliposomes encapsulating
    Bo R; Sun Y; Zhou S; Ou N; Gu P; Liu Z; Hu Y; Liu J; Wang D
    Int J Nanomedicine; 2017; 12():6289-6301. PubMed ID: 28894367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small cationic DDA:TDB liposomes as protein vaccine adjuvants obviate the need for TLR agonists in inducing cellular and humoral responses.
    Milicic A; Kaur R; Reyes-Sandoval A; Tang CK; Honeycutt J; Perrie Y; Hill AV
    PLoS One; 2012; 7(3):e34255. PubMed ID: 22470545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cubosomes containing the adjuvants imiquimod and monophosphoryl lipid A stimulate robust cellular and humoral immune responses.
    Rizwan SB; McBurney WT; Young K; Hanley T; Boyd BJ; Rades T; Hook S
    J Control Release; 2013 Jan; 165(1):16-21. PubMed ID: 23142776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Injectable and Pathogen-Mimicking Hydrogels for Enhanced Protective Immunity against Emerging and Highly Pathogenic Influenza Virus.
    Noh HJ; Noh YW; Heo MB; Kim EH; Park SJ; Kim YI; Choi YK; Lim YT
    Small; 2016 Dec; 12(45):6279-6288. PubMed ID: 27671946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biotin Functionalized Self-Assembled Peptide Nanofiber as an Adjuvant for Immunomodulatory Response.
    Demircan MB; Tohumeken S; Gunduz N; Khalily MA; Tekinay T; Guler MO; Tekinay AB
    Biotechnol J; 2020 Dec; 15(12):e2000100. PubMed ID: 32679620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of injectable hydrogel properties for slow co-delivery of influenza subunit vaccine components enhance the potency of humoral immunity.
    Saouaf OM; Roth GA; Ou BS; Smith AAA; Yu AC; Gale EC; Grosskopf AK; Picece VCTM; Appel EA
    J Biomed Mater Res A; 2021 Nov; 109(11):2173-2186. PubMed ID: 33955657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvancy enhancement of muramyl dipeptide by modulating its release from a physicochemically modified matrix of ovalbumin microspheres. II. In vivo investigation.
    Puri N; Sinko PJ
    J Control Release; 2000 Oct; 69(1):69-80. PubMed ID: 11018547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of different adjuvants in the context of intramuscular and intranasal routes on humoral and cellular immune responses induced by detergent-split A/H3N2 influenza vaccines in mice.
    Baz M; Samant M; Zekki H; Tribout-Jover P; Plante M; Lanteigne AM; Hamelin ME; Mallett C; Papadopoulou B; Boivin G
    Clin Vaccine Immunol; 2012 Feb; 19(2):209-18. PubMed ID: 22190392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving the Th1 cellular efficacy of the lead Yersinia pestis rF1-V subunit vaccine using SA-4-1BBL as a novel adjuvant.
    Dinc G; Pennington JM; Yolcu ES; Lawrenz MB; Shirwan H
    Vaccine; 2014 Sep; 32(39):5035-40. PubMed ID: 25045812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of AS03 and Alum on immune responses elicited by A/H3N2 split influenza vaccine in young, mature and aged BALB/c mice.
    Yam KK; Gupta J; Allen EK; Burt KR; Beaulieu É; Mallett CP; Burt DS; Ward BJ
    Vaccine; 2016 Mar; 34(12):1444-51. PubMed ID: 26873056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunopotentiation of Different Adjuvants on Humoral and Cellular Immune Responses Induced by HA1-2 Subunit Vaccines of H7N9 Influenza in Mice.
    Song L; Xiong D; Hu M; Kang X; Pan Z; Jiao X
    PLoS One; 2016; 11(3):e0150678. PubMed ID: 26930068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. One-pot synthesis and characterization of ovalbumin-conjugated gold nanoparticles: A comparative study of adjuvanticity against the physical mixture of ovalbumin and gold nanoparticles.
    Yang Y; Zhang Y; Thakur A; Li R; Xu H; Wang Z; Ghavami M; Tu Z; Liu H
    Int J Pharm; 2019 Nov; 571():118704. PubMed ID: 31536763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. pH-Responsive nanoparticle vaccines for dual-delivery of antigens and immunostimulatory oligonucleotides.
    Wilson JT; Keller S; Manganiello MJ; Cheng C; Lee CC; Opara C; Convertine A; Stayton PS
    ACS Nano; 2013 May; 7(5):3912-25. PubMed ID: 23590591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.